StockData
XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31

XORTX Therapeutics Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026
$1.01−0.23 (-18.55%)

Close on Oct 19, 2026

XORTX Therapeutics Inc. revenue by segment

No segment breakdown reported

XORTX Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.